Palestine News

Tezepelumab helps severe asthma patients reduce oral steroids over 28 weeks

Written by

wpadmin

in

Credit: Cnordic Nordic from Pexels

New results from the Phase III SUNRISE clinical trial show that tezepelumab significantly reduced the need for…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts